Bill Detail
H.R. 4101
Congress: 119
Title
Cancer Drug Parity Act of 2025
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Rep. Glenn Grothman [R-WI-6]
Status
Referred to the House Committee on Education and Workforce.
Status as of Jun 9, 9:50 PM · synced 20d ago
Introduced
2025-06-24
Data source mode: congress-gov
Bill Engagement
Cancer Drug Parity Act of 2025
Sponsor
Rep. Glenn Grothman [R-WI-6]R
Status
Referred to the House Committee on Education and Workforce.
Cosponsors
22D · 5R
Lean D
LDA engagement
1 org · 1 filing
Top: Association for Clinical Oncology
Introduced
2025-06-24
Lobbyists on the case
1 org · 2 lobbyists · 1 filing mention H.R. 4101 (Cancer Drug Parity Act of 2025) in LDA disclosures.
Top orgs filing
- Association for Clinical Oncology1 filing · 2 lobs
Lobbyists on this bill
- Katie Gifford2026 Q1
- Kristine Rufener2026 Q1